| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/10/2009 | EP1685254B1 Oncolytic herpes simplex virus encoding a heterologous nitroreductase |
| 06/10/2009 | EP1575981B1 Angiogenic acting tri-sulphate steroids and uses thereof |
| 06/10/2009 | EP1482961B1 Use of soluble fgl2 as an immunosuppressant |
| 06/10/2009 | EP1414797B9 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 06/10/2009 | EP1383869B1 Progenitor cell populations, expansion thereof, and growth of non-hematopoietic cell types and tissues therefrom |
| 06/10/2009 | EP1352070B1 A fibrin/fibrinogen-binding conjugate |
| 06/10/2009 | EP1289573B1 A medicinal aerosol antidiabetics formulation |
| 06/10/2009 | EP1141004B1 Proteins from rana pipiens and their use in the treatment of tumors |
| 06/10/2009 | EP1115421B1 Use of glp-1 or analogs in treatment of stroke |
| 06/10/2009 | EP1085900B1 Use of erythropoietin for the treatment of primary haemochromatoses |
| 06/10/2009 | EP0831892B1 Multimeric, recombinant urease vaccine |
| 06/10/2009 | EP0711303B2 Biotinylation of proteins |
| 06/10/2009 | CN101454451A C-class oligonucleotide analogs with enhanced immunostimulatory potency |
| 06/10/2009 | CN101454019A Rapid acting and long acting insulin combination formulations |
| 06/10/2009 | CN101454018A Methods for treating kidney disorders |
| 06/10/2009 | CN101454017A Method for elevating prolactin in mammals |
| 06/10/2009 | CN101454016A Methods of use and nutritional compositions of touchi extract |
| 06/10/2009 | CN101450205A Pig fusion protein preparation |
| 06/10/2009 | CN100497628C Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 06/10/2009 | CN100497619C Shingolipid ceramide deacylase gene |
| 06/10/2009 | CN100497610C Polypeptides encoded by human lipase-like gene and composition, and methods of utilizing same |
| 06/10/2009 | CN100497608C Human cholesteryl ester synthetase-2c and its coding sequence |
| 06/10/2009 | CN100497605C Anti cancer targeted regulatory gene-virus and construction method thereof |
| 06/10/2009 | CN100497604C Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
| 06/10/2009 | CN100497387C Chimeric proteins for cell targeting and apoptosis induction and methods of using same |
| 06/10/2009 | CN100497384C Novel gonadotropin-releasing hormone, precursor peptides thereof and genes encoding the same |
| 06/10/2009 | CN100497382C Antitumor effect of mutant bik |
| 06/10/2009 | CN100497379C Protein complex serving as vehicle for orally administerable medicaments |
| 06/10/2009 | CN100497377C SARS coronavirus structure protein ORF3 and its use |
| 06/10/2009 | CN100497376C Antimicrobial polypeptides |
| 06/10/2009 | CN100497375C Antimicrobial polypeptides |
| 06/10/2009 | CN100497374C N-formyl peptide receptor complex with a G-protein kinase signal pathway modification agent |
| 06/10/2009 | CN100497373C Novel melanocortin receptor templates, peptides, and use thereof |
| 06/10/2009 | CN100497372C Amidomethyl substituted 1-(carboxyalkyl)-cyclopentylcarbonylamino-benzazepine-N-acetic acid derivatives, process and intermediate products for their preparation and medicaments containing these compou |
| 06/10/2009 | CN100497370C Bursopoietin extracting method and its use in disease treating and immune |
| 06/10/2009 | CN100497369C Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof |
| 06/10/2009 | CN100496611C Preparations for topical skin use and treatment |
| 06/10/2009 | CN100496604C Storage-stable and bio-stable formulations of ACE inhibitors, and methods for preparation thereof |
| 06/10/2009 | CN100496476C Novel use of peptide compounds for treating central neuropathic pain |
| 06/10/2009 | CN100496298C Process for producing liquid formulation containing raw yeast and liquid formulation |
| 06/09/2009 | US7544855 Transgenic mouse whose genome comprises an APP having a mutation at amino acid 664 |
| 06/09/2009 | US7544853 C1 inhibitor with short half-life transient treatment |
| 06/09/2009 | US7544798 Halogenation and sulfonation of a 4-hydroxy-quinolone, ring closing metathesis with 2nd generation Hoveyda's catalyst of 2-(2-(cyclopropyl-2-propenyl)aminocarbonyl)-4-hydroxy-5-alkenoyl) pyrrolidine, etherification with the quinolone; one pot process; Hepatitis C viricides |
| 06/09/2009 | US7544790 Nucleotide sequences coding heavy chain of immunoglobulin specific for human tissue factor for use in prevention and treatment of thrombosis |
| 06/09/2009 | US7544788 Isolated nucleic acid molecule encoding a neurotrophic growth factor |
| 06/09/2009 | US7544784 The invention provides methods of increasing yields of desired conformation of proteins. In particular embodiments, the invention includes contacting preparations of a recombinant protein with a reduction/oxidation coupling reagent for a time sufficient to increase the relative proportion of a desired co |
| 06/09/2009 | US7544782 Tumour necrosis factor binding ligands |
| 06/09/2009 | US7544781 Polypeptide and process for producing the same |
| 06/09/2009 | US7544780 Prokaryotic collagen-like proteins and uses thereof |
| 06/09/2009 | US7544779 cysteine mutant proteins that bind to their cognate receptor or exhibit antiviral activity; polypeptides; fusion proteins |
| 06/09/2009 | US7544777 Porphorymonas gingivalis polypeptides and nucleotides |
| 06/09/2009 | US7544773 Antimicrobials against pathogenic bacteria and method for screening them |
| 06/09/2009 | US7544771 Identifying patients with or at risk of developing Alzheimer's Disease and other neurodegenerative diseases; purifying a biological sample and determining amount of protein biomarker |
| 06/09/2009 | US7544768 Peptides for inducing apoptosis in tumor cells |
| 06/09/2009 | US7544767 HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells |
| 06/09/2009 | US7544669 Polynucleotide therapy |
| 06/09/2009 | US7544666 NAP derivatives |
| 06/09/2009 | US7544665 Synthesis using peptide intermediate fragments |
| 06/09/2009 | US7544664 Sequences facilitating penetration of a substance of interest |
| 06/09/2009 | US7544662 Polypeptides useful for appetite suppression |
| 06/09/2009 | US7544661 Micellular reaction product of a peptide and a growth factor recognition ligand for growth factors selected from bone morphogenic protein-2, TGF- beta 1, VEGF, FGF-2, nerve growth factor-3 and laminin-5 and made from mesenchymal stem cells; improved bioavailability |
| 06/09/2009 | US7544660 Factor VIII polypeptide having factor VIII:C activity |
| 06/09/2009 | US7544659 Promotion of axonal regeneration |
| 06/09/2009 | US7544658 Heat resistant vacuole transport protein for use as nanoactuator of micromachine or nanomachine |
| 06/09/2009 | US7544657 Stabilized Exendin-4 compounds |
| 06/09/2009 | US7544656 Long acting injectable insulin composition and methods of making and using thereof |
| 06/09/2009 | US7544655 Novel amino acid sequences are within the carboxy termini of fibrinogen; useful for cell culture and cell separation |
| 06/09/2009 | US7544654 an octapeptide that selectively activates the Receptors for Activated C-Kinase (RACK) in cardiomyocytes and is linked to a tat-peptide or polyarginine peptide; peptide can be administered before, during or after the ischemic or hypoxic events; antiischemic, antihypoxic agents |
| 06/09/2009 | US7544653 Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone |
| 06/09/2009 | US7544519 Identifying modulators for prevention and treatment of infection, blood, metabolic, cell proliferative and respiratory system disorders |
| 06/09/2009 | US7544512 Transforming and fermenting gene products from cells comprising nucleotide sequences coding glucagon like polypeptides for use in stimulation and secretion of insulin; diabetes treatment; bioreactors |
| 06/09/2009 | US7544510 Stem cells of the islets of Langerhans and their use in treating diabetes mellitus |
| 06/09/2009 | US7544500 Process for the production of a reversibly inactive acidified plasmin composition |
| 06/09/2009 | US7544499 For treating an animal suffering from an excess of CHASEGP substrate produced from glial scar resulting from spinal cord injury or surgery; herniated disk; genetic engineering |
| 06/09/2009 | US7544492 Polynucleotide sequences coding human weight regulatory protein; therapy and diagnostic tool for eating disorders, cachexia; gene therapy; modulators of body weight |
| 06/09/2009 | US7544491 TANGO 240 nucleic acids and uses thereof |
| 06/09/2009 | US7544486 transfecting a mammalian cell with nucleic acid construct to express bone growth factor; implants; inducing osteogenic differentiation, osteoblastic mineralization and/or bone formation in clinical applications; lower doses of each growth factor hence cheaper; for treating bone disorders |
| 06/09/2009 | US7544485 Baldness related gene and the polypeptide encoded thereby, and uses |
| 06/09/2009 | US7544483 Method for the production of protamine |
| 06/09/2009 | US7544482 Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof |
| 06/09/2009 | US7544481 Nucleic acids encoding CD40 binding protein |
| 06/09/2009 | US7544480 drug screening an antagonist which inhibits hydroxylation of hypoxia inducible factor or an agonist which promotes hydroxylation of hypoxia inducible factor; hydroxylation of asparagine; antitumor agent; use for radiotherapy or chemotherapy |
| 06/09/2009 | US7544374 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 06/09/2009 | US7544368 A scaffold of biodegradable biopolymers including a combination of either collagen or gelatin and either chondroitin-6-sulfate, chondrotin-4-sulfate, heparin, heparan sulfate, keratan sulfate, dermatan sulfate, chitin, or chitosan; tissue engineering; glaucoma; antiscarring agents; kits; druug-free |
| 06/09/2009 | US7544364 reduced tissue accumulation of the glycopeptide antibiotic, reduced nephrotoxicity and reduced histamine release; side effect reduction |
| 06/09/2009 | US7544360 Peptide fragment with immunogenic or therapeutic properties against ischemic cardiovascular diseases |
| 06/09/2009 | US7544359 Antiischemic agents; anticholesterol agents; cardiovascular disorders |
| 06/09/2009 | US7544358 Bacterial sepsis, hemorrhagic shock, toxic inhalation, and bleomycin and other drug-induced lung injury; fibronectin and tenascin receptor antagonist; cancer |
| 06/09/2009 | US7544357 Administering an interferon antagonist and a FMS-like tyrosine kinase 3 ("Flt3") ligand antagonist, such as an anti-IFN-alpha antibody; in vitro assay for determining risk for developing an autoimmune disease |
| 06/09/2009 | US7544354 Methods of protein purification and recovery |
| 06/09/2009 | CA2441007C Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids |
| 06/09/2009 | CA2403721C Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
| 06/09/2009 | CA2388939C Therapeutic treatments for blood cell deficiencies |
| 06/09/2009 | CA2342861C Method and composition to protect an obligate carnivore from a disease of abnormal carbohydrate metabolism |
| 06/09/2009 | CA2317443C Agent for treating allergic or hypersensitivity condition |
| 06/09/2009 | CA2276183C Pharmaceutical preparations of glutathione and methods of administration thereof |
| 06/09/2009 | CA2269083C Novel fgf homologs |
| 06/09/2009 | CA2265521C Anti-bacterial composition for treating acne |
| 06/09/2009 | CA2251355C Il-6 mutein |
| 06/09/2009 | CA2199408C Herpes simplex virus glycoprotein d variants |